A specialized enterprise in the development and manufacturing of various biosignal diagnostic medical devices, including patient and fetal monitors, electrocardiographs, and animal diagnostic equipment.Aspecializedenterpriseinthedevelopmentandmanufacturingofvariousbiosignaldiagnosticmedicaldevices,includingpatientandfetalmonitors,electrocardiographs,andanimaldiagnosticequipment.
Key Products/TechnologiesKeyProducts/Technologies
Development and manufacturing capabilities for diverse biosignal diagnostic devices such as Patient Monitors (BPM-1200 PATRON, BPM-1010 MATRON, BPM-1000 MATRON, BPM-770 GUARDIAN, BPM-190 SENTRY PLUS, PalmCare plus), Fetal Monitors (BFM-900L, BFM-900), and Electrocardiographs (BCM-600, BCM-300).DevelopmentandmanufacturingcapabilitiesfordiversebiosignaldiagnosticdevicessuchasPatientMonitors(BPM-1200PATRON,BPM-1010MATRON,BPM-1000MATRON,BPM-770GUARDIAN,BPM-190SENTRYPLUS,PalmCareplus),FetalMonitors(BFM-900L,BFM-900),andElectrocardiographs(BCM-600,BCM-300).
Possession of network solutions and AI-based technologies, including AI CMS for 40-BED real-time central monitoring and N-marker, an AI program for disease diagnosis and abnormal sign detection.PossessionofnetworksolutionsandAI-basedtechnologies,includingAICMSfor40-BEDreal-timecentralmonitoringandN-marker,anAIprogramfordiseasediagnosisandabnormalsigndetection.
Core AdvantagesCoreAdvantages
Years of expertise and product diversity: Successful development and manufacturing of over 10 types of medical devices based on accumulated know-how in patient and fetal monitoring since its establishment in 2004.Yearsofexpertiseandproductdiversity:Successfuldevelopmentandmanufacturingofover10typesofmedicaldevicesbasedonaccumulatedknow-howinpatientandfetalmonitoringsinceitsestablishmentin2004.
Global quality standards and certifications: Establishment of international quality management systems such as MDD and ISO 13485, and acquisition of CE Mark for the European market, demonstrating adherence to strict quality criteria.Globalqualitystandardsandcertifications:EstablishmentofinternationalqualitymanagementsystemssuchasMDDandISO13485,andacquisitionofCEMarkfortheEuropeanmarket,demonstratingadherencetostrictqualitycriteria.
Extensive domestic and international distribution network: Efforts to expand overseas markets through over 50 distributors and 4 exclusive distributors worldwide, along with a nationwide network for the domestic market.Extensivedomesticandinternationaldistributionnetwork:Effortstoexpandoverseasmarketsthroughover50distributorsand4exclusivedistributorsworldwide,alongwithanationwidenetworkforthedomesticmarket.
Development of AI-based solutions: Securing future growth engines through the development of innovative network solutions and AI technologies like the central monitoring system (AI CMS) and disease diagnosis AI program (N-marker).DevelopmentofAI-basedsolutions:SecuringfuturegrowthenginesthroughthedevelopmentofinnovativenetworksolutionsandAItechnologieslikethecentralmonitoringsystem(AICMS)anddiseasediagnosisAIprogram(N-marker).
Price competitiveness and service: Provision of competitive pricing policies and comprehensive services alongside a diverse product range for enhanced customer satisfaction.Pricecompetitivenessandservice:Provisionofcompetitivepricingpoliciesandcomprehensiveservicesalongsideadiverseproductrangeforenhancedcustomersatisfaction.
Target IndustrieTargetIndustrie
Application in the human medical diagnostic industryApplicationinthehumanmedicaldiagnosticindustry
Provision of solutions for the veterinary medical diagnostic industryProvisionofsolutionsfortheveterinarymedicaldiagnosticindustry
Utilization in hospitals and clinics for patient monitoring and electrocardiogram diagnosisUtilizationinhospitalsandclinicsforpatientmonitoringandelectrocardiogramdiagnosis
Supply of fetal monitoring equipment in the obstetrics and gynecology sectorSupplyoffetalmonitoringequipmentintheobstetricsandgynecologysector
Major MarketsMajorMarkets
South AfricaSouthAfrica
India, China (FDA/SFDA application planned), Middle East regionIndia,China(FDA/SFDAapplicationplanned),MiddleEastregion
Germany, Italy, Russia and other European countriesGermany,Italy,RussiaandotherEuropeancountries
Preparation for FDA certification application for North American market entryPreparationforFDAcertificationapplicationforNorthAmericanmarketentry
Certifications/PatentsCertifications/Patents
Acquisition of international quality management system certifications ISO 13485 and MDD.AcquisitionofinternationalqualitymanagementsystemcertificationsISO13485andMDD.
Obtainment of CE Mark for entry into the European market.ObtainmentofCEMarkforentryintotheEuropeanmarket.
Planned applications for FDA certification for the North American market and SFDA certification for the Chinese market.PlannedapplicationsforFDAcertificationfortheNorthAmericanmarketandSFDAcertificationfortheChinesemarket.